Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$525,953
-$58,564 QoQ
Shares Held
4,163
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,345
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. GILD ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
|
21,612 | $1,036,079 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $525,953 | 4,163 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $584,517 | 4,194 | Shares | Sole | 2026-04-21 | |
| 2025-06-30 | $355,005 | 3,202 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,219,888 | 10,887 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,031,957 | 11,172 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $717,251 | 8,555 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $505,518 | 7,368 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $512,310 | 6,994 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $621,346 | 7,670 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $616,681 | 8,229 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $783,570 | 10,167 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $660,939 | 7,966 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $445,218 | 5,186 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $371,682 | 6,025 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $372,405 | 6,025 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $318,295 | 5,354 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $388,753 | 5,354 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $372,789 | 5,337 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $350,084 | 5,084 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $329,548 | 5,099 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $277,317 | 4,760 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $301,037 | 4,764 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $408,705 | 5,312 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $402,582 | 5,385 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||